Hologic, Inc.  Notes to Consolidated Financial Statements (continued) (In thousands, except per share data) The aggregate purchase price for Suros of approximately $248,000 (subject to adjustment) consisted of 2,300 shares of Hologic Common Stock valued at $106,500, cash paid of $139,000, and approximately $2,600 for acquisition related fees and expenses.
The Company determined the fair value of the shares issued in connection with the acquisition in accordance with EITF Issue No.99-12, Determination of the Measurement Date for the Market Price of Acquirer Securities Issued in a Purchase Business Combination.
The components and allocation of the purchase price, consists of the following approximate amounts:
## Table 0 ##
The acquisition also provides for a two-year earn out.
The earn-out will be payable in two annual cash installments equal to the incremental revenue growth in Suros’ business in the two years following the closing.
The Company has considered the provision of EITF Issue No.95-8, Accounting for Contingent Consideration Paid to the Shareholders of and Acquired Enterprise in a Purchase Business Combination, and concluded that this contingent consideration represents additional purchase price.
As a result, goodwill will be increased by the amount of the additional consideration, if any, when it becomes due and payable.
As part of the purchase price allocation, all intangible assets that were a part of the acquisition were identified and valued.
It was determined that only customer lists, trademarks and developed technology had separately identifiable values.
Customer relationships represents Suros large installed base that are expected to purchase disposable products on a regular basis.
Trademarks represent the Suros product names that the Company intends to continue to use.
Developed technology represents currently marketable purchased products that the Company continues to resell as well as utilize to enhance and incorporate into the Company’s existing products.
The estimated $4,900 of purchase price allocated to in-process research and development projects primarily related to Suros’ Disposable products.
The projects are of various stages of completion and include next generation handpiece and site marker technologies.
The Company expects that these projects will be completed during fiscal 2007.
The deferred income tax liability relates to the tax effect of acquired identifiable intangible assets, and fair value adjustments to acquired inventory as such amounts are not deductible for tax purposes, partially offset by acquired net operating loss carry forwards that the Company believes are realizable.
For all of the acquisitions discussed above, goodwill represents the excess of the purchase price over the net identifiable tangible and intangible assets acquired.
The Company determined that the acquisition of each AEG, R2 and Suros resulted in the recognition of goodwill primarily because of synergies unique to the Company and the strength of its acquired workforce.
Supplemental Pro-forma Information The following unaudited pro forma information presents the consolidated results of operations of the Company, R2 and Suros as if the acquisitions had occurred at the beginning of each of fiscal 2006 and 2005,
GAIN INCOME AND LOANS SOLD
## Table 1 ##
(1) Beginning in fiscal 2008, the effects of changes in valuation assumptions or funding costs related to loans originated and sold during previous quarters of the same fiscal year are presented in gain on sales of loans originated and sold.
Previously, these adjustments were reported in other losses or gains.
These adjustments totaled $(35.9) million in fiscal 2008.
As a result, the sum of amounts previously reported for interim quarters will not equal the total reported for fiscal 2008.
The impact of similar adjustments for prior fiscal years was not material.
The gain on sales of loans originated and sold includes both the gain income recorded at the time of securitization and the effect of any subsequent changes in valuation assumptions or funding costs that are incurred in the same fiscal year that the loans were originated.
Other losses or gains include the effects of changes in valuation assumptions or funding costs related to loans originated and sold during previous fiscal years.
In addition, other losses or gains could include the effects of new public securitizations, changes in the valuation of retained subordinated bonds and the resale of receivables in existing public securitizations, as applicable.
In the 2008-1 public securitization, we held $44.7 million of subordinated bonds, because the economics of doing so were more favorable than selling them in the public market.
Our public securitizations typically contain an option to repurchase the securitized receivables when the outstanding balance in the pool of auto loan receivables falls below 10% of the original pool balance.
This option was exercised two times in each of fiscal 2008, 2007 and 2006.
In each case, the remaining eligible receivables were subsequently resold into the warehouse facility.
These transactions did not have a material effect on CAF income in fiscal 2008, 2007 or 2006.
Fiscal 2008 Versus Fiscal 2007.
CAF income declined 35% to $85.9 million in fiscal 2008, reflecting the disruption in the global credit markets and worsening economic conditions.
The gain on sales of loans originated and sold decreased 33% to $58.1 million in fiscal 2008.
In the second half of the fiscal year, credit spreads in the asset-backed securities market widened, resulting in a substantial increase in CAF’s funding costs.
In addition, we increased the discount rate assumption used to calculate our gain on sales of loans to 17% from 12%, and we increased our cumulative net loss assumptions on loans originated and sold during fiscal 2008 to a range of 2.7% to 3.0%, which was significantly higher than the cumulative net loss assumptions used on loans originated in fiscal 2007.
As a result, the gain percentage declined to 2.4% in fiscal 2008 compared with 3.9% in fiscal 2007.
We recognized other losses of $9.6 million, or $0.03 per share, in fiscal 2008, which included the effects of the increase in the discount rate and cumulative net loss assumptions on loans originated and sold in previous years.
Other losses also included a $2.7 million reduction in the carrying value of the retained subordinated bonds.
In fiscal 2007, we recognized other gains of $13.0 million, or $0.04 per share, which included the effects of reducing cumulative net loss assumptions on loans originated and sold in previous years.
The increases in other CAF income and other direct CAF expenses in fiscal 2008 were proportionate to the growth in managed receivables during the year.
Fiscal 2007 Versus Fiscal 2006.
CAF income rose 27% to $132.6 million in fiscal 2007.
CAF income benefited from the growth in retail vehicle unit sales, increases in the gain percentage, average amount financed and total managed receivables.
The gain percentage increased to 3.9% in fiscal 2007 from 3.5% in fiscal 2006, reflecting
The discount rate assumptions used to account for pension and other postretirement benefit plans reflect the rates at which the benefit obligations could be effectively settled.
Rates for U. S.  and certain non-U.
S.  plans at December 31, 2018 were determined using a cash flow matching technique whereby the rates of a yield curve, developed from high-quality debt securities, were applied to the benefit obligations to determine the appropriate discount rate.
For other non-U.
S.  plans, we base the discount rate on comparable indices within each of the countries.
The Company measures the service cost and interest cost components of net periodic benefit cost for pension and other postretirement benefit plans by applying the specific spot rates along the yield curve to the plans’ projected cash flows.
The rate of compensation increase assumption is determined by the Company based upon annual reviews.
The expected long-term rate of return assumption for U. S.  pension plan assets is based upon the target asset allocation and is determined using forward-looking assumptions in the context of historical returns and volatilities for each asset class, as well as correlations among asset classes.
We evaluate the rate of return assumption on an annual basis.
The expected long-term rate of return assumption used in computing 2018 net periodic pension cost for the U. S.  plans was 8.00 percent.
As of December 31, 2018, the 5-year, 10-year and 15-year annualized return on plan assets for the primary U. S.  plan was 5.5 percent, 9.2 percent and 6.4 percent, respectively.
The annualized return since inception was 10.3 percent.
The assumed health care cost trend rates are as follows:
## Table 2 ##
We review external data and our own historical trends for health care costs to determine the health care cost trend rate assumptions.
The Company’s U. S.  postretirement benefit plans are primarily defined dollar benefit plans that limit the effects of medical inflation because the plans have established dollar limits for determining our contributions.
As a result, the effect of a 1 percentage point change in the assumed health care cost trend rate would not be significant to the Company.
Cash Flows Our estimated future benefit payments for funded and unfunded plans are as follows (in millions):
## Table 3 ##
1 The expected benefit payments for our other postretirement benefit plans are net of estimated federal subsidies expected to be received under the Medicare Prescription Drug, Improvement and Modernization Act of 2003.
Federal subsidies are estimated to be $3 million for the period 2019-2023 and $2 million for the period 2024-2028.
The Company anticipates making pension contributions in 2019 of $32 million, all of which will be allocated to our international plans.
The majority of these contributions are required by funding regulations or law.
Defined Contribution Plans Our Company sponsors qualified defined contribution plans covering substantially all U. S.  employees.
Under the largest U. S.  defined contribution plan, we match participants’ contributions up to a maximum of 3.5 percent of compensation, subject to certain limitations.
Company costs related to the U. S.  plans were $39 million, $61 million and $82 million in 2018, 2017 and 2016, respectively.
We also sponsor defined contribution plans in certain locations outside the United States.
Company costs associated with those plans were $33 million, $35 million and $37 million in 2018, 2017 and 2016, respectively.
Multi-Employer Pension Plans The Company participates in various multi-employer pension plans.
Multi-employer pension plans are designed to cover employees from multiple employers and are typically established under collective bargaining agreements.
These plans allow multiple employers to pool their pension resources and realize efficiencies associated with the daily administration of the plan.
Multi-employer plans are generally governed by a board of trustees composed of management and labor representatives and are funded through employer contributions.
The Company’s expense for multi-employer pension plans totaled $6 million, $35 million and $41 million in 2018, 2017 and 2016, respectively.
The decrease in 2018 was primarily driven by the refranchising of certain bottling territories in the United States during
## Table 4 ##
(1) Includes “trading account assets supporting insurance liabilities” and other fixed maturities classified as trading securities under U. S.  GAAP, but are held for “other than trading” activities in our segments that offer insurance, retirement and annuities products.
(2) The hypothetical change in fair value related to our variable annuity and other living benefit feature embedded derivatives reflects only the gross fair value change on the embedded derivatives, and excludes any offsetting impact of derivative instruments purchased to hedge such changes in fair value.
(3) Included in “Other liabilities” together with all liabilities of consolidated variable interest entities.
See Note 5 to the Consolidated Financial Statements for additional information regarding consolidated variable interest entities.
The tables above do not include approximately $154 billion of insurance reserve and deposit liabilities as of December 31, 2009 and $152 billion as of December 31, 2008 which are not considered financial liabilities.
We believe that the interest rate sensitivities of these insurance liabilities would serve as an offset to the net interest rate risk of the financial assets and liabilities, including investment contracts, which are set forth in these tables.
Our net estimated potential loss in fair value as of December 31, 2009 increased $1,407 million from December 31, 2008, primarily reflecting an increase in our fixed maturity securities portfolio in 2009.
The increase in our fixed maturity securities portfolio in 2009 was primarily due to a net increase in fair value driven by credit spread tightening, portfolio growth as a result of reinvestment of net investment income, the impact of foreign currency, and the acquisition of Yamato Life.
The estimated changes in fair values of our financial assets shown above relate primarily to assets invested to support our insurance liabilities, but do not include separate account assets associated with products for which investment risk is borne primarily by the separate account contractholders rather than by us.
Market Risk Related to Equity Prices We actively manage investment equity price risk against benchmarks in respective markets.
We benchmark our return on equity holdings against a blend of market indices, mainly the S&P 500 and Russell 2000 for U. S.  equities.
For foreign equities we benchmark against the Tokyo Price Index, or TOPIX, and the MSCI EAFE, a market index of European, Australian, and Far Eastern equities.
We target price sensitivities that approximate those of the benchmark indices.
We estimate our investment equity price risk from a hypothetical 10% decline in equity benchmark market levels and measure this risk in terms of the decline in fair market value of equity securities we hold.
Using this methodology, our estimated investment equity price risk as of December 31, 2009 was $809 million, representing a hypothetical decline in fair market value of equity securities we held at that date from $8.091 billion to $7.282 billion.
Our estimated investment equity price risk using this methodology as of December 31, 2008 was $680 million, representing a hypothetical decline in fair market value of equity securities we held at that date from $6.803 billion to $6.123 billion.
In calculating these amounts, we exclude separate account equity securities related to products for which the investment risk is borne primarily by the separate account contractholder rather than by us.
In addition to equity securities, as indicated above, we hold equity-based derivatives primarily to hedge the equity price risk embedded in the living benefit features in some of our variable annuity products.
As of December 31, 2009, our equity-based derivatives had notional values of $7.126 billion, and were reported at fair value as a $532 million asset, and the living benefit features accounted for as embedded derivatives were reported at fair value as a $55 million liability.
As of December 31, 2008, our equity-based derivatives had notional values of $7.353 billion, and were reported at fair value as a $1.908 billion asset, and the living benefits features accounted for as embedded derivatives were reported at fair value as a $3.229 billion liability.
Our estimated equity price risk associated with living benefit features accounted for as embedded derivatives, net of the related equity-based derivatives used in our living benefits hedging program, was a $61 million benefit as of December 31, 2009 and a less than $10 million benefit as of December 31, 2008, estimated based on a hypothetical 10% decline in equity benchmark market levels.
The higher sensitivity level as of December 31, 2009 primarily reflects the impact of our own risk on non-performance on the embedded derivative liabilities, which does not have an offsetting impact on the hedge assets.
See

['

Net tangible assets acquired as of July 27, 2006	$12,000
In-process research and development	4,900
Developed technology and know how	46,000
Customer relationship	17,900
Trade name	5,800
Deferred income taxes	-21,300
Goodwill	182,800
Estimated Purchase Price	$248,100

', '

Years Ended February 29 or 28
(In millions)	2008	2007	2006
Gain on sales of loans originated and sold-1	$58.1	$86.7	$61.9
Other (losses) gains(1)	-9.6	13.0	15.2
Total gain income	$48.5	$99.7	$77.1
Loans originated and sold	$2,430.8	$2,240.2	$1,792.6
Receivables repurchased from public securitizations andresold	103.6	82.5	94.8
Total loans sold	$2,534.4	$2,322.7	$1,887.5
Gain percentage on loans originated and sold	2.4%	3.9%	3.5%
Total gain income as a percentage of total loans sold	1.9%	4.3%	4.1%

', '

December 31,	2018	2017
Health care cost trend rate assumed for next year	7.00%	7.00%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)	5.00%	5.00%
Year that the rate reaches the ultimate trend rate	2023	2022

', '

Year Ended December 31,	2019	2020	2021	2022	2023	2024–2028
Pension benefit payments	$439	$448	$460	$468	$480	$2,517
Other benefit payments1	62	61	59	57	55	250
Total estimated benefit payments	$501	$509	$519	$525	$535	$2,767

', '

As of December 31, 2008
Notional	Fair Value	Hypothetical Fair Value After +100 Basis Point Parallel Yield CurveShift	Hypothetical Change in Fair Value
(in millions)
Financial assets with interest rate risk:
Fixed maturities-1	$174,724	$163,212	$-11,512
Commercial mortgage and other loans	30,570	29,474	-1,096
Policy loans	12,697	11,782	-915
Derivatives:
Swaps	$100,331	1,853	393	-1,460
Futures	7,345	-50	-301	-251
Options	5,371	1,895	1,758	-137
Forwards	9,996	-143	-188	-45
Variable annuity and other living benefit feature embedded derivatives-2	-3,229	-2,255	974
Financial liabilities with interest rate risk:
Short-term and long-term debt	-27,051	-25,227	1,824
Debt of consolidated variable interest entities-3	-167	-167	—
Investment contracts	-69,933	-67,882	2,051
Bank customer liabilities	-1,354	-1,347	7
Net estimated potential loss	$-10,560

']

Question: How many Notional exceed the average of Notional in 2008?
Answer: 1